{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T17:40:14Z","timestamp":1756834814417,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.cpcardiol.2025.103144","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T22:30:21Z","timestamp":1754433021000},"page":"103144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expanding the concept of pharma-cise: A graphical primer for clinicians, researchers and industry"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6675-1996","authenticated-orcid":false,"given":"Ross","family":"Arena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolaas P.","family":"Pronk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2025.103144_bib0001","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1161\/CIR.0b013e31826fb946","article-title":"EACPR\/AHA scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations","volume":"126","author":"Guazzi","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0002","doi-asserted-by":"crossref","first-page":"e694","DOI":"10.1161\/CIR.0000000000000406","article-title":"2016 Focused update: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations","volume":"133","author":"Guazzi","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0003","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pcad.2024.02.009","article-title":"Assessing cardiorespiratory fitness in clinical and community settings: lessons and advancements in the 100th year anniversary of VO(2max)","volume":"83","author":"Harber","year":"2024","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0004","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.1161\/CIR.0000000000000461","article-title":"Importance of assessing cardiorespiratory fitness in clinical practice: a case for fitness as a clinical vital sign: a scientific statement from the American Heart Association","volume":"134","author":"Ross","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-4-79","article-title":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance","volume":"4","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2021.100879","article-title":"An evolving approach to assessing cardiorespiratory fitness, muscle function and bone and joint health in the COVID-19 era","volume":"47","author":"Arena","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0007","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.cpcardiol.2015.01.009","article-title":"Exercise testing in heart failure","volume":"40","author":"Myers","year":"2015","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145960","article-title":"Prediction of cardiorespiratory fitness by the six-minute step test and its association with muscle strength and power in sedentary obese and lean young women: a cross-sectional study","volume":"10","author":"Carvalho","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0009","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2147\/COPD.S350133","article-title":"Respiratory effects of treatment with a glucagon-like peptide-1 receptor agonist in patients suffering from obesity and chronic obstructive pulmonary disease","volume":"17","author":"Altintas Dogan","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0010","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1111\/dom.15557","article-title":"The effect of glucagon-like peptide-1 receptor agonists on cardiac function and structure in patients with or without type 2 diabetes mellitus: an updated systematic review and meta-analysis","volume":"26","author":"Zhang","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0011","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/01.hjh.0001115440.99912.21","article-title":"Effects of the glp-1 RA semaglutide on vascular structure and function in patients with type 2 diabetes: results of a prospective randomized double-blind placebo-controlled study","volume":"43","author":"Kannenkeril","year":"2025","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0012","doi-asserted-by":"crossref","first-page":"bvae122","DOI":"10.1210\/jendso\/bvae122","article-title":"Semaglutide concurrently improves vascular and liver indices in patients with type 2 diabetes and fatty liver disease","volume":"8","author":"Korakas","year":"2024","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13677","article-title":"The effects of glucagon-like peptide-1 receptor agonists on mitochondrial function within skeletal muscle: a systematic review","volume":"16","author":"Old","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"10","key":"10.1016\/j.cpcardiol.2025.103144_bib0014","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12178-025-09978-3","article-title":"The effects of GLP-1 agonists on musculoskeletal health and orthopedic care","volume":"18","author":"Gatto","year":"2025","journal-title":"Curr Rev Musculoskelet Med."},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/phar.70005","article-title":"The potential role of GLP-1 receptor agonists in osteoarthritis","volume":"45","author":"Ryan","year":"2025","journal-title":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0016","article-title":"Liraglutide prevents and reverses monocrotaline-induced pulmonary arterial hypertension by suppressing ET-1 and enhancing eNOS\/sGC\/PKG pathways","volume":"6","author":"Lee","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0017","article-title":"GLP-1 receptor agonists and pulmonary hypertension in diabetes: a promising therapeutic strategy","volume":"55","author":"Albulushi","year":"2025","journal-title":"Am Heart J Plus"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0018","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/cvr\/cvae120","article-title":"Glucagon-like peptide-1 increases heart rate by a direct action on the sinus node","volume":"120","author":"Lubberding","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0019","doi-asserted-by":"crossref","first-page":"901","DOI":"10.4093\/dmj.2021.0314","article-title":"Effect of the glucagon-like peptide-1 receptor agonists on autonomic function in subjects with diabetes: a systematic review and meta-analysis","volume":"46","author":"Greco","year":"2022","journal-title":"Diabetes Metab J"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103144_bib0020","doi-asserted-by":"crossref","first-page":"H235","DOI":"10.1152\/ajpheart.00809.2024","article-title":"Heart and health behavior responses to GLP-1 receptor agonists: a 12-wk study using wearable technology and causal inference","volume":"328","author":"Grosicki","year":"2025","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0021","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S2213-8587(24)00272-9","article-title":"Muscle matters: the effects of medically induced weight loss on skeletal muscle","volume":"12","author":"Prado","year":"2024","journal-title":"The Lancet Diabetes & Endocrinology"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0022","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/dom.15728","article-title":"Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies","author":"Neeland","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0023","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1161\/CIRCULATIONAHA.124.067676","article-title":"Muscle mass and glucagon-like peptide-1 receptor agonists: adaptive or maladaptive response to weight loss?","volume":"150","author":"Linge","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0024","first-page":"1794","article-title":"Integrating diet and physical activity when prescribing GLP-1s-lifestyle factors remain crucial","author":"Mehrtash","year":"2025","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0025","doi-asserted-by":"crossref","first-page":"e2416775","DOI":"10.1001\/jamanetworkopen.2024.16775","article-title":"Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: a secondary analysis of a randomized clinical trial","volume":"7","author":"Jensen","year":"2024","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0026","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.mayocp.2024.07.007","article-title":"Pharma-cise in the glucagon-like peptide-1 receptor agonists era: a concept whose time has come","volume":"99","author":"Arena","year":"2024","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cpcardiol.2025.103144_bib0027","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/00913847.2015.1001938","article-title":"Exercise is medicine: a call to action for physicians to assess and prescribe exercise","volume":"43","author":"Sallis","year":"2015","journal-title":"Phys Sportsmed"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280625001641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280625001641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T17:05:57Z","timestamp":1756832757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280625001641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0146280625001641"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2025.103144","relation":{},"ISSN":["0146-2806"],"issn-type":[{"type":"print","value":"0146-2806"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanding the concept of pharma-cise: A graphical primer for clinicians, researchers and industry","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2025.103144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103144"}}